systematic_review
    2021
    High Quality

    Propionyl-L-carnitine for intermittent claudication

    Delaney CL, Spark JI, Thomas J

    Published in Cochrane Database of Systematic Reviews

    Key Findings

    Low-certainty evidence that propionyl-L-carnitine may improve maximum walking distance versus placebo.

    Conclusions

    Evidence too weak to recommend routinely for claudication.

    Limitations

    Small industry-funded trials, imprecision.

    Supplements Studied

    L-Carnitine
    Amino Acid

    Low-certainty evidence suggests propionyl-L-carnitine may improve maximum walking distance compared with placebo.

    Related Health Concerns

    Peripheral Artery Disease

    Study Details

    Year:2021
    Sample Size:1,153
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.